Lifeboat Foundation

A novel computer algorithm, or set of rules, that accurately predicts the orbits of planets in the solar system could be adapted to better predict and control the behavior of the plasma that fuels fusion facilities designed to harvest on Earth the fusion energy that powers the sun and stars.

The algorithm, devised by a scientist at the U.S. Department of Energy’s (DOE) Princeton Plasma Physics Laboratory (PPPL), applies machine learning, the form of artificial intelligence (AI) that learns from experience, to develop the predictions. “Usually in physics, you make observations, create a theory based on those observations, and then use that theory to predict new observations,” said PPPL physicist Hong Qin, author of a paper detailing the concept in Scientific Reports. “What I’m doing is replacing this process with a type of black box that can produce accurate predictions without using a traditional theory or law.”

Qin (pronounced Chin) created a computer program into which he fed data from past observations of the orbits of Mercury, Venus, Earth, Mars, Jupiter, and the dwarf planet Ceres. This program, along with an additional program known as a “serving algorithm,” then made accurate predictions of the orbits of other planets in the solar system without using Newton’s laws of motion and gravitation. “Essentially, I bypassed all the fundamental ingredients of physics. I go directly from data to data,” Qin said. “There is no law of physics in the middle.”

UK-based BenevolentAI has dosed the first patient in its first-in-human clinical trial of its novel multi-target drug, BEN-2293, for treating atopic dermatitis (AD).

Designed and developed using BenevolentAI’s scientific and technical expertise, BEN-2293 is a potent and selective small-molecule Pan-Trk antagonist formulated for topical delivery.

BenevolentAI has dosed the first patient in its clinical trial of its novel multi-target drug, BEN-2293, for treating atopic dermatitis (AD).

A Romanian threat researcher detailed in a published report Wednesday how he broke into IT systems belonging to some of the largest corporations in the world. His assaults successfully targeted Apple, Microsoft, Tesla, PayPal, Netflix and more than 30 other corporations.

Researchers at the Max Planck Institute for Intelligent Systems (MPI-IS) and ETH Zürich have recently created HuggieBot 2.0, a robot that can hug users at their request. This robot, set to be presented at the ACM/IEEE International Conference on Human-Robot Interaction (HRI) in March, builds on a previous robotic system created by Alexis E. Block, one of the authors, during her Master’s degree.

A novel state of matter has been discovered by physicists at the University of Leicester.

In recent years, active, self-propelled particles have received growing interest amongst the scientific community. Examples of active particles and their systems are numerous and very diverse, ranging from bacterium films to flocks of birds or human crowds. These systems can demonstrate unusual behavior, which is challenging to understand or model.

To this end, large-scale models of active particles were being scrutinized by experts at Leicester, in order to understand basic principles underlying active particle dynamics and apply them in a scenario of an evacuation strategy for customers in crowded place. Unexpectedly, the ‘super-particles’ milling in a circular motion were stumbled upon by Leicester’s physicists who subsequently coined the phenomenon as “swirlonic.”

A team, including an astronomer from the University of Hawaiʻi Institute for Astronomy (IfA), have confirmed a planetoid that is almost four times farther from the Sun than Pluto, making it the most distant object ever observed in our solar system. The planetoid, nicknamed “Farfarout,” was first det.

This work provides evidence for something scientists predicted long ago.

Scientists have spotted the first evidence of a rare Higgs boson decay, expanding our understanding of the strange quantum universe.

With nine vaccines now showing they can powerfully prevent severe illness and death from #COVID19—and vaccines in short supply—researchers are mulling an issue that, even a few months ago, was only hypothetical: Should people mix and match vaccines that require two shots?

Scarce vaccine supplies ramp up interest in combining different doses.

An Israeli drug that has been successful in initial trials, could hold a key in blunting the COVID-19 pandemic. Thirty patients in serious condition participated in the trial and all recovered, most of them in less than a week. Sonya Cohen was one of them and she could one day be seen as a walking #miracle.

Follow Jerusalem Dateline and download the CBN News app to ensure you keep receiving news from a Christian Perspective. go.cbn.com/cbnapp.

#covidcure #Israel #Israeli #innovation #fightcovid #breakthrough.
Ichilov Hospital, Tel Aviv